Becker Lev, Kheirandish-Gozal Leila, Peris Eduard, Schoenfelt Kelly Q, Gozal David
Section of Pediatric Sleep Medicine, Department of Pediatrics, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL, USA.
Section of Pediatric Sleep Medicine, Department of Pediatrics, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL, USA.
Sleep Med. 2014 May;15(5):541-9. doi: 10.1016/j.sleep.2014.01.010. Epub 2014 Feb 7.
Intrinsic variance of the urine proteome limits the discriminative power of proteomic analysis and complicates potential biomarker detection in the context of paediatric sleep disorders.
Using a rigorous workflow for proteomic analysis of urine, we demonstrate that gender and diurnal effects constitute two important sources of variability in healthy children. In the context of disease, complex pathophysiological perturbations magnify these proteomic differences and therefore require contextualised biomarker analysis. Indeed, by performing biomarker discovery in a gender- and diurnal-dependent manner, we identified ∼30-fold more candidate biomarkers of paediatric obstructive sleep apnoea (OSA), a highly prevalent condition in children characterised by repetitive episodes of intermittent hypoxia and hypercapnia, and sleep fragmentation in the context of recurrent upper airway obstructive events during sleep. Remarkably, biomarkers were highly specific for gender and sampling time as poor overlap (∼3%) was observed in the proteins identified in boys and girls across morning and bedtime samples.
As no clinical basis to explain gender-specific effects in OSA or healthy children is apparent, we propose that implementation of contextualised biomarker strategies will be applicable to a broad range of human diseases, and may be specifically applicable to paediatric OSA.
尿液蛋白质组的内在变异性限制了蛋白质组学分析的鉴别能力,并使儿科睡眠障碍背景下潜在生物标志物的检测变得复杂。
通过使用严格的尿液蛋白质组学分析流程,我们证明性别和昼夜效应是健康儿童变异性的两个重要来源。在疾病背景下,复杂的病理生理扰动会放大这些蛋白质组学差异,因此需要进行背景化生物标志物分析。事实上,通过以性别和昼夜依赖的方式进行生物标志物发现,我们发现小儿阻塞性睡眠呼吸暂停(OSA)的候选生物标志物多出约30倍,OSA是一种在儿童中高度普遍的疾病,其特征是间歇性缺氧和高碳酸血症反复发作,以及睡眠期间反复出现上呼吸道阻塞事件时的睡眠片段化。值得注意的是,生物标志物对性别和采样时间具有高度特异性,因为在早晨和就寝时间样本中,男孩和女孩鉴定出的蛋白质重叠率很低(约3%)。
由于在OSA或健康儿童中没有明显的临床依据来解释性别特异性效应,我们建议实施背景化生物标志物策略将适用于广泛的人类疾病,并且可能特别适用于小儿OSA。